Strategic Marketing The MYND Group specializes in strategic marketing and managed care solutions for pharmaceutical and biologics companies, presenting opportunities to pitch value-added market access programs and payer-facing strategies.

Acquisition Context Acquired by Fingerpaint Group, The MYND Group sits within a larger healthcare collective, signaling potential for cross-sell of integrated marketing, payer engagement, and access services to a broader client base.

Therapeutic Breadth With experience across cardiovascular, metabolics, neuroscience, oncology, respiratory, anti-infectives, immunology, pain, and women’s health, there are multiple high-demand therapeutic areas to target with managed markets offerings.

Tech & Compliance Utilizes cloud, analytics, e-signature, training, and content platforms (AWS, Adobe Experience Cloud, Google Analytics, DocuSign, KnowBe4, Microsoft 365), indicating readiness for scalable, compliant payer and HCP engagement programs.

Growth Signals Revenue in the mid-range (10M–25M) and a clear focus on market access enablement suggest opportunities to expand services through additional managed care solutions, patient access programs, and payer contract optimization for existing and prospective clients.